Journal Information
Vol. 35. Issue. 4.July - August 2015
Pages 347-420
Download PDF
More article options
Vol. 35. Issue. 4.July - August 2015
Pages 347-420
Letters to the Editor – Brief papers about basic research or clinical experiences
DOI: 10.1016/j.nefroe.2015.08.001
Open Access
The relationship between serum and urine NGAL and graft function in pediatric renal transplant recipients
Relación entre niveles de NGAL en suero y orina y función del injerto en pacientes pediátricos trasplantados renales
Sepideh Hekmata,
Corresponding author

Corresponding author.
, Hasan Otukeshb, Nahid Rahimzadehb, Rozita Hoseinib
a Iran University of Medical Sciences, Iran
b Iran University of Medical Sciences, Pediatric Transplantation and Dialysis Research Center, Iran
Article information
Full Text
Download PDF
Full Text
Dear Editor,

We previously serially measured the serum and urine neutrophil gelatinase associated lipocalin (NGAL) during the first week after renal transplantation and found that mild ischemic injury may increase this lipocalin.1 In this study, we investigated the level of this marker after one month post-transplant with the aim of finding a relationship between NGAL quantities and graft function.

Twenty-one pediatric renal transplant recipients without any infection at the time of assessment were included in this study. Glomerular filtration rate was estimated by Schwartz equation and DTPA scan concurrently. Scintigraphic measurement of GFR was performed using an ADAC single-headed gamma camera with the following formula:

Pre-post – k: kidney count; b: background count; x: renal depth; e: constant; μ: attenuation coefficient of 99mTc in soft tissue (0.153cm−1); GFR=total renal uptake percent (%)×100×9.812706.82519.

The mean age of patients was 9.9±3 years old. Nine patients (43%) were male. The mean time from transplantation was 6.8±2.47 years. The mean serum creatinine was 1.16±0.18mg/dl. The mean Schwartz calculated GFR was 69.8±12.2cc/min/1.73m2. The mean DTPA measured GFR was 50.6±16cc/min/1.73m2. All patients had GFR less than 90cc/min/1.73m2 by scan and Schwartz formula. The mean serum NGAL was 140±94ng/ml (15–324ng/ml). The mean urine NGAL was 17.8ng/ml (3.2–68ng/ml).

We assessed the correlation between serum NGAL and serum creatinine, Schwartz GFR, and DTPA-related GFR. The coefficient of correlation with serum creatinine was 0.67 (P=0.09), −0.2 (P=0.3) with Schwartz GFR, and −0.26 (P=0.46) with DTPA GFR. Regarding urine NGAL, the correlation coefficient with serum creatinine was 0.2 (P=0.37), −0.007 (P=0.9) with Schwartz GFR, and −0.24 (P=0.48) with DTPA GFR.

We did not find any significant association between the transplant time and serum NGAL (r=0.05, P=0.8) and urine NGAL (r=0.06, P=0.77). Three patients had slow graft function in this study without need for dialysis in the first week post-transplant. The mean serum and urine NGAL was not different between patients with SGF and those without SGF (for serum NGAL 106 vs 145.5ng/ml and for urine NGAL 12.2 vs 21.6ng/ml).

Studies have shown that expression of NGAL protein is significantly increased during ischemic insults in renal transplant recipients with delayed graft function.2 Magnusson et al. have shown that plasma NGAL levels were significantly higher than normal in renal transplant recipients.3 Malyszko et al. also found a strong correlation between serum NGAL and serum creatinine in 100 kidney transplant recipients.4

This study is the first study in pediatric renal transplant recipients in which the association between serum and urine NGAL with graft function was assessed long term. We did not find any significant association between the amounts of NGAL in serum and urine with serum creatinine and GFR estimated by Schwartz formula or measured by DTPA scan. We think we cannot use serum and urine NGAL as markers of graft function in pediatric renal transplant recipients, but this result needs confirmation by more studies with more cases.

N. Rahimzadeh, H. Otukesh, R. Hoseini, H. Sorkhi, M. Otukesh, S. Hoseini, et al.
Are serum and urine neutrophil gelatinase associated lipocalin predictive of renal graft function in short term?.
Pediatr Transplant, 16 (2012), pp. 796-802
J. Mishra, Q. Ma, C. Kelly, M. Mitsnefes, K. Mori, J. Barasch, et al.
Kidney NGAL is a novel early marker of acute injury following transplantation.
Pediatr Nephrol, 21 (2006), pp. 856-863
N.E. Magnusson, M. Hornum, K.A. Jørgensen, J.M. Hansen, C. Bistrup, B. Feldt-Rasmussen, et al.
Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation.
BMC Nephrol, 10 (2012), pp. 8
J. Malyszko, J.S. Malyszko, M. Mysliwiec.
Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients.
Clin Transplant, 23 (2009), pp. 681-686
Nefrología (English Edition)

Subscribe to our newsletter

Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.